{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:33:06Z","timestamp":1786480386162,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2023R1A2C3005307"],"award-info":[{"award-number":["2023R1A2C3005307"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1I1A1A01073047"],"award-info":[{"award-number":["2022R1I1A1A01073047"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00352229"],"award-info":[{"award-number":["RS-2024-00352229"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbrc.2025.153166","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:08:30Z","timestamp":1766102910000},"page":"153166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Regulation of BAP1 activity by novel cancer-associated glutamate residues through ubiquitin binding and PARylation"],"prefix":"10.1016","volume":"797","author":[{"given":"Jiyeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8992-2092","authenticated-orcid":false,"given":"So-Yeon","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mooyoung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunbo","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0913-8706","authenticated-orcid":false,"given":"Sun-Shin","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6491-6024","authenticated-orcid":false,"given":"Jongbum","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.153166_bib1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2025.153166_bib2","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","article-title":"BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization","volume":"68","author":"Ventii","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.153166_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s12276-023-00979-1","article-title":"BAP1 as a guardian of genome stability: implications in human cancer","volume":"55","author":"Kwon","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2025.153166_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41418-020-00709-4","article-title":"Roles and mechanisms of BAP1 deubiquitinase in tumor suppression","volume":"28","author":"Masclef","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2025.153166_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41420-021-00406-2","article-title":"Emerging multifaceted roles of BAP1 complexes in biological processes","volume":"7","author":"Szczepanski","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbrc.2025.153166_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature08966","article-title":"Histone H2A deubiquitinase activity of the polycomb repressive complex PR-DUB","volume":"465","author":"Scheuermann","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.153166_bib7","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1128\/MCB.01517-08","article-title":"Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1","volume":"29","author":"Misaghi","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.153166_bib8","doi-asserted-by":"crossref","first-page":"34179","DOI":"10.1074\/jbc.M109.046755","article-title":"The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1","volume":"284","author":"Machida","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.153166_bib9","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1128\/MCB.00396-10","article-title":"The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression","volume":"30","author":"Yu","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.153166_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.1309085110","article-title":"Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair","volume":"111","author":"Yu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bbrc.2025.153166_bib11","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","article-title":"Germ-line mutations in BAP1 impair its function in DNA double-strand break repair","volume":"74","author":"Ismail","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.153166_bib12","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1038\/ncomms6128","article-title":"Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis","volume":"5","author":"Lee","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.153166_bib13","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1042\/BCJ20190622","article-title":"BAP1 promotes stalled fork restart and cell survival via INO80 in response to replication stress","volume":"476","author":"Lee","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2025.153166_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.14348\/molcells.2021.2258","article-title":"CHIP and BAP1 act in concert to regulate INO80 ubiquitination and stability for DNA replication","volume":"44","author":"Seo","year":"2021","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bbrc.2025.153166_bib15","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1038\/s41467-020-16589-8","article-title":"BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice","volume":"11","author":"Perkail","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.153166_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41419-018-0500-6","article-title":"BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma","volume":"9","author":"Sime","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2025.153166_bib17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.153166_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature22798","article-title":"BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation","volume":"546","author":"Bononi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.153166_bib19","article-title":"BAP1 suppresses tumor development by inducing ferroptosis upon SLC7A11 repression","volume":"6","author":"Zhang","year":"2019","journal-title":"Mol. Cell Oncol."},{"key":"10.1016\/j.bbrc.2025.153166_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.aav4902","article-title":"Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1","volume":"364","author":"He","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.153166_bib21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.molcel.2014.03.002","article-title":"Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O","volume":"54","author":"Mashtalir","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2025.153166_bib22","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2025.153166_bib23","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2025.153166_bib24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pena-Llopis","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2025.153166_bib25","first-page":"402","article-title":"Mesothelioma: scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2025.153166_bib26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbrc.2025.153166_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep18462","article-title":"Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: a new insight in enzymatic inactivation","volume":"5","author":"Bhattacharya","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.153166_bib28","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171099","article-title":"Ubiquitin recognition of BAP1: understanding its enzymatic function","volume":"37","author":"Hanpude","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbrc.2025.153166_bib29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1158\/0008-5472.CAN-17-2876","article-title":"Familial and somatic BAP1 mutations inactivate ASXL1\/2-Mediated allosteric regulation of BAP1 deubiquitinase by targeting multiple independent domains","volume":"78","author":"Peng","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.153166_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167553","article-title":"Impacts of cancer-associated mutations on the structure-activity relationship of BAP1","volume":"434","author":"Puri","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2025.153166_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202500372","article-title":"Characterization of BRCA1-Associated Protein-1 (BAP1) aggregation properties induced by cancer-associated mutations","author":"Hsiao","year":"2025","journal-title":"Chembiochem"},{"key":"10.1016\/j.bbrc.2025.153166_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-022-01024-w","article-title":"BAP1 promotes the repair of UV-induced DNA damage via PARP1-mediated recruitment to damage sites and control of activity and stability","author":"Lee","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2025.153166_bib33","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s41598-023-29017-w","article-title":"Targeting BAP1 with small compound inhibitor for colon cancer treatment","volume":"13","author":"Kang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2025.153166_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41586-023-05841-y","article-title":"Basis of the H2AK119 specificity of the Polycomb repressive deubiquitinase","volume":"616","author":"Ge","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.153166_bib35","doi-asserted-by":"crossref","first-page":"eadg9832","DOI":"10.1126\/sciadv.adg9832","article-title":"Structural basis of histone H2A lysine 119 deubiquitination by polycomb repressive deubiquitinase BAP1\/ASXL1","volume":"9","author":"Thomas","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2025.153166_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263322","article-title":"Biolayer interferometry for DNA-protein interactions","volume":"17","author":"Barrows","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.153166_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152982","article-title":"PARP1 cooperates with ASXL1 to stimulate BAP1 deubiquitinase activity through its DNA-binding domain","volume":"792","author":"Lee","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.153166_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113970","article-title":"UCH-L3 structure and function: insights about a promising drug target","volume":"227","author":"Hafez","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.153166_bib39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.molcel.2015.01.016","article-title":"Structural basis for the activation and inhibition of the UCH37 deubiquitylase","volume":"57","author":"Vander Linden","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2025.153166_bib40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.bbrc.2009.10.062","article-title":"Crystal structure of the de-ubiquitinating enzyme UCH37 (human UCH-L5) catalytic domain","volume":"390","author":"Nishio","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2025.153166_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-15-0295","article-title":"Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer","volume":"76","author":"Ohar","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.153166_bib42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3376","article-title":"New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs","volume":"13","author":"Gibson","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.153166_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-025-04082-5","article-title":"Restoration of BAP1 activity via base editing suppresses anchorage-independent survival in kidney cancer","author":"Lee","year":"2025","journal-title":"Cancer Cell Int."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25018820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25018820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:16:38Z","timestamp":1786479398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25018820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"alternative-id":["S0006291X25018820"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153166","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of BAP1 activity by novel cancer-associated glutamate residues through ubiquitin binding and PARylation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153166"}}